An Eternal Dilemma: Exposing the Impact of Immortal Time Bias on Antifibrotic Effectiveness.

In the early-start cohort, there was a nonsignificant trend toward a mortality benefit compared with those who initiated treatment after 2 months.

also in 5,406 other papers